Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Cash Flow-to-Debt Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Cash Flow-to-Debt Ratio of 0.42x as of September 2025, meaning its operating cash flow of CN¥425.83 Million could theoretically repay 0% of its total liabilities (CN¥1.00 Billion) in one year. See 002262 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. Also explore net asset momentum of Jiangsu Nhwa Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Year-by-year debt coverage analysis for Jiangsu Nhwa Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Jiangsu Nhwa Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.90x | CN¥1.08 Billion | CN¥1.20 Billion | ▲ +14.9% |
| 2024 | 0.79x | CN¥916.13 Million | CN¥1.17 Billion | ▼ -28.5% |
| 2023 | 1.10x | CN¥1.01 Billion | CN¥918.09 Million | ▲ +14.5% |
| 2022 | 0.96x | CN¥861.02 Million | CN¥897.43 Million | ▲ +8.6% |
| 2021 | 0.88x | CN¥701.12 Million | CN¥793.45 Million | ▼ -50.0% |
| 2020 | 1.77x | CN¥1.25 Billion | CN¥706.67 Million | ▲ +244.5% |
| 2019 | 0.51x | CN¥305.97 Million | CN¥596.68 Million | ▲ +36.2% |
| 2018 | 0.38x | CN¥404.52 Million | CN¥1.07 Billion | ▼ -30.1% |
| 2017 | 0.54x | CN¥452.35 Million | CN¥840.24 Million | ▲ +65.3% |
| 2016 | 0.33x | CN¥277.14 Million | CN¥850.97 Million | ▲ +15.4% |
| 2015 | 0.28x | CN¥204.24 Million | CN¥723.60 Million | ▲ +52.1% |
| 2014 | 0.19x | CN¥160.24 Million | CN¥863.61 Million | ▼ -30.3% |
| 2013 | 0.27x | CN¥194.33 Million | CN¥730.13 Million | ▲ +14.4% |
| 2012 | 0.23x | CN¥154.16 Million | CN¥662.41 Million | ▲ +54.3% |
| 2011 | 0.15x | CN¥81.08 Million | CN¥537.59 Million | ▲ +20.0% |
| 2010 | 0.13x | CN¥61.79 Million | CN¥491.74 Million | ▼ -21.1% |
| 2009 | 0.16x | CN¥61.27 Million | CN¥384.68 Million | ▲ +32.1% |
| 2008 | 0.12x | CN¥46.50 Million | CN¥385.66 Million | ▲ +10.4% |
| 2007 | 0.11x | CN¥48.55 Million | CN¥444.39 Million | ▲ +34.5% |
| 2006 | 0.08x | CN¥30.99 Million | CN¥381.63 Million | ▲ +228.0% |
| 2005 | 0.02x | CN¥8.84 Million | CN¥357.12 Million | — |